GILD · NASDAQ · Healthcare · Drug Manufacturers - General

Gilead Sciences

—Past month
Price unavailable
  • 52W range114.02–160.51
  • Market cap193.89B

Latest news

Loading...

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in p...

gilead.com